Generated by GPT-5-mini| Leibniz Institute for Natural Product Research and Infection Biology | |
|---|---|
| Name | Leibniz Institute for Natural Product Research and Infection Biology |
| Established | 1992 |
| Type | Research institute |
| City | Jena |
| State | Thuringia |
| Country | Germany |
Leibniz Institute for Natural Product Research and Infection Biology is a German research institute focused on natural products chemistry and microbial infection biology. The institute combines expertise in medicinal chemistry, microbiology, and structural biology to investigate bioactive compounds from microbes, plants, and marine sources. Its work intersects with applied biomedical research, drug discovery, and biodiversity studies.
The institute traces origins to research traditions in Jena and the legacy of chemical and biological research in Thuringia, consolidating laboratories that previously associated with institutions such as Friedrich Schiller University Jena, Max Planck Society, and regional research centers. During the 1990s reorganization of German research after reunification, the institute aligned with the Leibniz Association framework and developed partnerships with organizations including the German Research Foundation and the European Molecular Biology Laboratory. Historical ties link to prominent figures in natural product chemistry and microbiology from institutions like University of Bonn, University of Freiburg, and University of Hamburg that influenced its scientific directions. Over time, the institute expanded through collaborations with European programs such as Horizon 2020 and networks involving the Wellcome Trust and the Alexander von Humboldt Foundation.
Research spans natural products discovery, microbial pathogenesis, and chemical biology. Departments and research groups draw on methodologies from structural determination by comparisons to work at European Synchrotron Radiation Facility, metabolomics strategies paralleling groups at EMBL, and genomic approaches influenced by standards from the European Nucleotide Archive. Key thematic areas resonate with programs at University of Oxford, Harvard University, and Johns Hopkins University in drug discovery, while antibiotic resistance research engages with initiatives like the World Health Organization action plans. The institute hosts departments focusing on natural product chemistry, infection biology, microbial genomics, and bioinformatics, and it interacts with consortia including IMI and CEOS style networks. Research outputs are coordinated with peer communities represented by journals and societies such as Nature Communications, The Lancet Infectious Diseases, and the American Society for Microbiology.
State-of-the-art facilities include mass spectrometry platforms comparable to those at Max Planck Institute for Chemical Ecology, high-field NMR spectrometers used in laboratories like University of Cambridge, and crystallography resources paralleling capabilities at Diamond Light Source. The institute maintains culture collections and biobanks akin to DSMZ and genomic sequencing infrastructure interfacing with repositories such as GenBank. Advanced microscopy suites reflect technology used at ETH Zurich and core bioinformatics servers enable data sharing consistent with ELIXIR standards. Collections of microbial strains and natural extracts foster collaborations with museums and herbaria including Botanical Garden, University of Jena and regional natural history museums.
The institute participates in national and international networks, cooperating with universities such as Friedrich Schiller University Jena, University of Leipzig, and University of Munich and research organizations like the Helmholtz Association and Fraunhofer Society. It contributes to European research consortia alongside partners including Karolinska Institutet, CNRS, and Francis Crick Institute. Collaborative projects have linked the institute with pharmaceutical companies and NGOs similar to Bayer and Gates Foundation initiatives, and with clinical centers such as Charité – Universitätsmedizin Berlin and University Hospital Jena for translational studies. Memberships and cooperative agreements extend to networks such as the Leibniz Association research infrastructures and international task forces coordinated by WHO and UNESCO.
The institute provides postgraduate training and doctoral supervision in partnership with Friedrich Schiller University Jena and international exchanges with institutions like ETH Zurich and University of Cambridge. It hosts workshops and summer schools modeled after programs at EMBL and exchanges fellows supported by the Alexander von Humboldt Foundation and Marie Skłodowska-Curie Actions. Training covers techniques taught in curricula at Max Planck Institutes and integrates internships with industrial partners comparable to placement schemes at Boehringer Ingelheim and collaborative training networks affiliated with the German Academic Exchange Service.
Governance follows statutes aligned with the Leibniz Association oversight and administrative practices similar to those at the Max Planck Society. Funding sources include federal and state allocations coordinated with the Thuringian Ministry for Education, Science and Culture, competitive grants from the German Research Foundation, European framework programmes such as Horizon Europe, and project funding from philanthropic organizations like the Wellcome Trust. The institute’s advisory boards include external scientists affiliated with institutions including University of Oxford, Harvard Medical School, and Karolinska Institutet to ensure strategic alignment with international research priorities.
Category:Research institutes in Germany Category:Biological research institutes